Renishaw plc (RNSHF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Renishaw plc (RNSHF) trades at $65.80 with AI Score 54/100 (Grade B). Renishaw plc is an engineering and scientific technology company that designs, manufactures, distributes, sells, and services metrology and healthcare products globally. Market cap: $4.79B, Sector: Technology.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for RNSHF: RNSHF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RNSHF against Technology peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
RNSHF: 3/7 perspectives are bullish. Dominant signal: Ken Griffin bearish.
How is this calculated? →Renishaw plc (RNSHF) Technology Profile & Competitive Position
Renishaw plc is a UK-headquartered engineering and scientific technology company specializing in metrology and healthcare products. It provides precision measurement systems, additive manufacturing solutions, and advanced medical devices to global industries like aerospace, automotive, and healthcare, maintaining a diverse product portfolio and international distribution network.
What Is the Investment Thesis for RNSHF?
Renishaw plc presents an investment profile characterized by its robust market position in precision engineering and healthcare technology, supported by solid financial metrics. With a market capitalization of $4.79B and a gross margin of 52.1%, the company demonstrates strong operational efficiency in its specialized product segments. Its profit margin stands at 10.1%, indicating effective cost management relative to its revenue. A P/E ratio of 49.7 suggests that investors anticipate future growth, reflecting confidence in its innovative product pipeline and market expansion capabilities. The company's dividend yield of 1.55% offers a return to shareholders, while its Beta of 1.10 indicates a slightly higher volatility compared to the broader market. Key growth catalysts include the increasing global demand for precision manufacturing across industries like aerospace and automotive, driving sales of its metrology products. Furthermore, the expanding adoption of advanced medical technologies, such as neurosurgical robots and customized implants, positions Renishaw to capitalize on the growing healthcare market. The company's ongoing investment in additive manufacturing systems also provides a long-term growth driver as industries increasingly adopt these advanced production methods. Potential value drivers include continued innovation in its core technologies, strategic partnerships, and expansion into emerging markets, leveraging its established global distribution network.
Based on FMP financials and quantitative analysis
RNSHF Key Highlights
- Market Capitalization of $4.79B, reflecting its significant presence in the engineering and scientific technology sector.
- Gross Margin of 52.1%, indicating strong profitability from its specialized metrology and healthcare product sales.
- Profit Margin of 10.1%, demonstrating efficient management of operational costs relative to revenue.
- P/E Ratio of 49.7, suggesting investor expectations for future earnings growth driven by technological innovation.
- Dividend Yield of 1.55%, providing a return to shareholders while maintaining capital for reinvestment in R&D and expansion.
Who Are RNSHF's Competitors?
RNSHF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| TYOYY Taiyo Yuden Co., Ltd. | $493.28 | -10.24% | $15.43B | — |
| ASUUY ASUSTeK Computer Inc. | $115.00 | +0.00% | $17.08B | 48 |
| HRIBF HORIBA, Ltd. | $162.47 | +0.00% | $6.82B | 54 |
| AUOTY AUO Corporation | $9.12 | -2.25% | $6.88B | 49 |
| HPHTY Hamamatsu Photonics K.K. | $8.08 | +0.00% | $4.71B | 50 |
| MDA Macdonald Dettwiler & Associate | $40.75 | +3.16% | $5.65B | 66 |
| WATT Energous Corporation | $24.09 | +0.84% | $35.78M | 65 |
| APH Amphenol Corporation | $164.59 | -4.43% | $202.48B | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RNSHF's Key Strengths?
- Diverse product portfolio spanning metrology and healthcare technologies.
- Strong global presence and distribution network.
- High gross margin (52.1%) indicating efficient production and value.
- Continuous innovation through R&D in precision engineering.
What Are RNSHF's Weaknesses?
- Relatively high P/E ratio (48.59) suggesting high growth expectations that must be met.
- Beta of 1.10 indicates slightly higher market volatility.
- Reliance on capital expenditure cycles of industrial customers.
- Exposure to global economic downturns impacting manufacturing and healthcare spending.
What Could Drive RNSHF Stock Higher?
- Continued adoption of Renishaw's additive manufacturing systems in industrial production, driving equipment sales and service revenue.
- Expansion of its neurosurgical robotics and medical device portfolio into new geographic markets, leveraging existing distribution channels.
- Potential new product launches in advanced metrology or healthcare technology, enhancing competitive differentiation and market share.
- Increased demand for precision measurement solutions across the aerospace and automotive sectors, fueled by stricter quality standards and automation trends.
- Strategic partnerships or collaborations that could broaden Renishaw's technological capabilities or market access in specialized segments.
What Are the Key Risks for RNSHF?
- Rich valuation — a P/E of 49.7 runs well above the Technology sector’s ~38x, leaving little room for a miss.
- Intense competition within both the metrology and healthcare technology markets, potentially impacting pricing power and market share.
- Economic downturns or reduced capital expenditure by key industrial customers, leading to decreased demand for high-value equipment.
- Regulatory changes or increased scrutiny in the medical device sector, which could affect product development, approval, and market entry.
- Fluctuations in foreign exchange rates, given its global operations and UK headquarters, impacting reported earnings.
- Supply chain disruptions or increased raw material costs, which could affect production timelines and gross margins.
What Are the Growth Opportunities for RNSHF?
- Expansion in Additive Manufacturing: The global additive manufacturing market is projected to continue its rapid expansion, driven by demand for complex geometries, lightweight components, and rapid prototyping across industries like aerospace, medical, and automotive. Renishaw's additive manufacturing systems, including metal and plastics vacuum casting machines, position it to capitalize on this trend. As companies increasingly adopt 3D printing for production, Renishaw's integrated solutions, from design to post-processing, offer a significant advantage. The market is expected to grow substantially over the next 5-10 years, providing a sustained revenue stream for the company.
- Growing Demand for Precision Metrology: Industries such as automotive, aerospace, and consumer electronics are continuously pushing the boundaries of precision engineering, requiring increasingly sophisticated metrology solutions. Renishaw's comprehensive suite of CMM products, machine tool probes, and performance measurement systems directly addresses this need. The trend towards Industry 4.0 and smart factories necessitates real-time, highly accurate measurement and control, ensuring Renishaw's offerings remain critical. This market is stable and growing, particularly in advanced manufacturing hubs, offering long-term growth potential for the company's core business over the next decade.
- Advancements in Neurosurgical Technology: The healthcare sector is experiencing significant innovation in surgical robotics and personalized medicine. Renishaw's neurosurgical robots, planning software, and drug delivery systems are at the forefront of this evolution. As healthcare providers seek less invasive procedures and improved patient outcomes, the adoption of advanced neurosurgical tools is expected to accelerate. The market for medical robotics and precision surgical instruments is expanding globally, presenting a substantial growth opportunity for Renishaw's healthcare division over the next 3-7 years, driven by an aging population and technological progress.
- Development of Advanced Encoder Technologies: The demand for high-accuracy motion control and position feedback systems is critical in various high-tech applications, including semiconductor manufacturing, scientific instrumentation, and automated machinery. Renishaw's interferometric laser, magnetic, and optical encoders are essential components in these systems. As industries strive for higher throughput and greater precision, the market for advanced encoders is set for sustained growth. Renishaw's continuous innovation in this area ensures its competitive edge, with market expansion anticipated over the next 5-8 years as industrial automation and robotics proliferate.
- Customized Implants and Medical Devices: The trend towards personalized healthcare and patient-specific solutions is driving demand for customized medical implants, particularly in craniomaxillofacial surgery. Renishaw's expertise in additive manufacturing and precision engineering allows it to produce highly customized implants. This niche but high-value market segment offers significant growth potential, as personalized medicine becomes more prevalent. The ability to provide bespoke solutions, coupled with its existing healthcare product portfolio, positions Renishaw to capture a larger share of this specialized market over the next 5-10 years.
What Opportunities Does RNSHF Have?
- Growing adoption of additive manufacturing across various industries.
- Increasing demand for advanced robotics and automation in healthcare and manufacturing.
- Expansion into emerging markets for precision engineering and medical devices.
- Strategic partnerships to broaden product offerings and market reach.
What Threats Does RNSHF Face?
- Intense competition from specialized and diversified technology companies.
- Rapid technological advancements requiring continuous R&D investment.
- Supply chain disruptions affecting manufacturing and distribution.
- Regulatory changes in the medical device sector impacting product development and market access.
What Are RNSHF's Competitive Advantages?
- Proprietary technology and extensive patent portfolio in metrology and additive manufacturing.
- Deep engineering expertise and R&D capabilities leading to innovative, high-precision products.
- Strong global brand reputation for quality and reliability in specialized industrial and medical markets.
- Integrated solutions combining hardware, software, and services, creating customer stickiness.
- Extensive global distribution and service network providing localized support and market penetration.
What Does RNSHF Do?
Renishaw plc, incorporated in 1973 and headquartered in Wotton-under-Edge, United Kingdom, has evolved into a global leader in engineering and scientific technology. The company's core business revolves around the design, manufacture, distribution, sale, and servicing of a comprehensive range of metrology and healthcare products. In its metrology division, Renishaw offers sophisticated solutions critical for precision manufacturing across various industries. This includes co-ordinate measuring machine (CMM) products, which are fundamental for quality control and dimensional inspection, alongside machine tool probe and software systems that enhance manufacturing efficiency and accuracy. The company also provides performance measurement systems, gauging systems, fixtures, and styli for touch probe systems, all designed to ensure high precision in industrial applications. Furthermore, Renishaw is a key player in advanced measurement technologies, offering interferometric laser, magnetic, and optical encoders that are vital for motion control and position feedback in high-performance systems. The company has also made significant strides in additive manufacturing, providing advanced systems for creating complex parts layer by layer, as well as plastics and metal vacuum casting machines. Its product portfolio extends to mapping sensors, which are crucial for various industrial and scientific applications. Beyond industrial metrology, Renishaw has a substantial presence in the healthcare sector, developing innovative products that address critical medical needs. This includes dental scanners for digital dentistry, neurosurgical robots and accessories that assist in complex brain surgeries, and specialized neurosurgical planning software. The company also contributes to medical science with drug delivery systems, advanced Raman microscopes for chemical analysis, craniomaxillofacial customized implants for reconstructive surgery, analysers, and hybrid Raman systems. These healthcare offerings underscore Renishaw's commitment to applying its engineering expertise to improve patient outcomes and diagnostic capabilities. Renishaw plc's extensive product and service portfolio caters to a broad spectrum of industries globally. Its client base spans aerospace, agriculture, automotive, construction, consumer electronics, power generation, resource exploration, energy, heavy industry, and precision manufacturing. In the healthcare sector, it serves medical device manufacturers, hospitals, and research institutions. The company also provides specialized services such as asset financing and travel agency services, further diversifying its operational scope. With 5256 employees, Renishaw maintains a significant global footprint, ensuring its advanced technological solutions reach diverse markets worldwide and solidify its position as a critical technology provider in both industrial and medical fields.
What Products and Services Does RNSHF Offer?
- Designs and manufactures co-ordinate measuring machine (CMM) products for precision inspection.
- Develops machine tool probes and software to enhance manufacturing efficiency.
- Provides performance measurement systems, gauging systems, and fixtures for industrial applications.
- Produces advanced interferometric laser, magnetic, and optical encoders for motion control.
- Offers additive manufacturing systems and vacuum casting machines for 3D printing and prototyping.
- Develops healthcare products including dental scanners, neurosurgical robots, and customized implants.
- Sells and services its metrology and healthcare products globally, serving diverse industries.
- Provides specialized services such as asset financing and travel agency services.
How Does RNSHF Make Money?
- Generates revenue through the direct sale of its proprietary metrology and healthcare hardware products.
- Earns income from associated software licenses, maintenance contracts, and service agreements for its systems.
- Provides installation, training, and ongoing technical support, contributing to recurring service revenue.
- Monetizes its additive manufacturing expertise through system sales and related materials.
- Offers niche services like asset financing and travel agency services, diversifying revenue streams.
What Industry Does RNSHF Operate In?
Renishaw plc operates within the dynamic Technology sector, specifically in Hardware, Equipment & Parts, with a significant footprint in both industrial metrology and healthcare technology. The company is positioned as a specialist provider of high-precision engineering solutions, serving critical industries that demand accuracy and reliability, such as aerospace, automotive, and medical device manufacturing. Current market trends indicate a growing demand for automation, digital manufacturing, and advanced quality control systems, all of which align with Renishaw's core competencies in CMM products, machine tool probes, and additive manufacturing. In the healthcare segment, the trend towards minimally invasive surgery, personalized medicine, and advanced diagnostics drives demand for its neurosurgical robots, dental scanners, and Raman microscopes. The competitive landscape includes specialized players in metrology and medical technology. Renishaw differentiates itself through its integrated approach, offering both hardware and software solutions, and its strong R&D capabilities that foster continuous innovation. Its global distribution and service network further strengthen its competitive standing in these high-value markets.
Who Are RNSHF's Key Customers?
- Aerospace and automotive manufacturers requiring high-precision measurement and production tools.
- Healthcare providers and medical device companies utilizing neurosurgical robots, dental scanners, and implants.
- Consumer electronics and precision manufacturing industries seeking advanced quality control and automation.
- Scientific, research, and analysis industries employing Raman microscopes and specialized sensors.
- Companies in power generation, resource exploration, energy, and heavy industries needing robust metrology solutions.
ROE 8%Key Financial Metrics
Return on equity for Renishaw plc stands at 8.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.7%, showing how much profit it generates from its asset base. RNSHF trades at a trailing price-to-earnings ratio of 49.65, above the Technology sector average of ~38x. Its free cash flow yield is 1.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 4.57 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.0%, the inverse of the P/E and a quick read on earnings relative to price.
Renishaw plc (RNSHF) Valuation Context
Valued at $4.79B, RNSHF is classified as a mid-cap stock. Relative to its peer group, RNSHF's quantitative score of 54/100 is roughly in line with the peer average of 50/100.
Company Profile
Renishaw plc operates in the Hardware, Equipment & Parts industry within the Technology sector. It is headquartered in Wotton-under-Edge, GB. The company is led by CEO William Ernest Lee. RNSHF has traded publicly since 2013.
F-Score 5/9Financial Health
Renishaw plc's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 14.41 places it in the safe zone, indicating low near-term bankruptcy risk.
FY2026 estForward Outlook
Wall Street analysts project Renishaw plc revenue of about $781.2M for fiscal 2026, with EPS near $1.67. The estimate reflects 3 contributing analysts.
RNSHF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future, indicating that executives believe in the growth potential.
- Community sentiment has shifted positively, with discussions highlighting Renishaw's innovation in precision engineering and growing demand.
- The company has been gaining traction in the healthcare sector, particularly with its advanced manufacturing technologies.
- Market perception is bolstered by the increasing trend of automation and digital manufacturing, where Renishaw's products are seen as essential.
Bear Case
- Concerns over global supply chain disruptions may impact Renishaw's ability to meet demand, creating uncertainty among investors.
- Some community members express skepticism about the company's ability to maintain its competitive edge amid rising competition in advanced manufacturing.
- Recent fluctuations in the semiconductor market could pose risks for Renishaw, affecting production timelines and costs.
- There are ongoing worries about potential regulatory challenges in key markets that could hinder growth prospects.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
RNSHF Latest News
-
Renishaw plc (RNSHF) Analyst/Investor Day Transcript
seekingalpha.com · Jun 16, 2026
-
Renishaw Highlights AI Chip, Defense and Additive Growth at Capital Markets Day
marketbeat.com · Jun 16, 2026
-
Stocks That Hit 52-Week Lows On Thursday
· Feb 27, 2020
RNSHF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RNSHF.
Price Targets
Wall Street price target analysis for RNSHF.
RNSHF MoonshotScore
What does this score mean?
The MoonshotScore rates RNSHF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Hardware, Equipment & PartsLeadership: William Ernest Lee
Managing Director
William Ernest Lee serves as the Managing Director of Renishaw plc, overseeing a global workforce of 5256 employees. While specific details regarding his educational background and prior career roles are not provided, his leadership at Renishaw indicates a significant tenure and expertise within the engineering and scientific technology sectors. His role involves steering the company's strategic direction, product development, and global market expansion across its diverse metrology and healthcare divisions. His experience is critical in navigating the complexities of high-precision manufacturing and advanced medical technology markets.
Track Record: Under William Ernest Lee's leadership, Renishaw plc has maintained its position as a key innovator in metrology and healthcare. His strategic decisions have supported the development and global distribution of advanced products, including neurosurgical robots and additive manufacturing systems. The company's consistent gross margin of 52.1% and profit margin of 10.1% suggest effective operational management and a focus on high-value offerings during his tenure.
RNSHF OTC Market Information
Renishaw plc trades on the OTC (Over-The-Counter) market under the "OTC Other" tier. This tier is distinct from major exchanges like the NYSE or NASDAQ, which have stringent listing requirements regarding financial reporting, minimum share price, and corporate governance. "OTC Other" generally refers to securities that do not meet the disclosure requirements for OTCQX or OTCQB, or choose not to be listed on those tiers. Companies in this tier may not provide regular financial reports to the SEC, making it more challenging for investors to access comprehensive, standardized financial information compared to exchange-listed companies.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Public Information: The "Unknown" disclosure status means there may be a lack of readily available, standardized financial reports and company updates, hindering informed investment decisions.
- Lower Liquidity: Trading on the "OTC Other" tier often results in lower trading volumes and wider bid-ask spreads, making it difficult to buy or sell shares quickly or at favorable prices.
- Price Volatility: Due to lower liquidity and less regulatory oversight, OTC stocks can be subject to greater price volatility and manipulation compared to exchange-listed securities.
- Lack of Transparency: The absence of stringent reporting requirements can lead to less transparency regarding company operations, financials, and corporate governance.
- Difficulty in Valuation: Limited financial data and analyst coverage can make it challenging for investors to accurately value the company and assess its intrinsic worth.
- Seek out any available company financial statements or annual reports directly from the company or its website.
- Investigate the company's corporate governance practices and management team's track record.
- Research any news or press releases from reputable financial news sources regarding Renishaw plc.
- Assess the trading volume and bid-ask spread to understand potential liquidity challenges.
- Examine the company's primary listing (if any) on a foreign exchange for more comprehensive reporting.
- Consult with a financial advisor experienced in OTC markets regarding the specific risks.
- Verify the company's business operations and market position through independent industry reports.
- Established Operating History: Incorporated in 1973, indicating a long-standing business operation.
- Headquartered in the UK: Suggests adherence to UK corporate regulations, even if OTC in the US.
- Significant Employee Count: 5256 employees indicates a substantial, active business rather than a shell company.
- Diverse Product Portfolio: Offers a wide range of tangible metrology and healthcare products, demonstrating real business activities.
- Global Reach: Serves various industries worldwide, indicating a legitimate and widespread commercial presence.
Renishaw plc Technology Stock: Key Questions Answered
How does Renishaw plc generate revenue from its technology products?
Renishaw plc generates revenue primarily through the design, manufacture, and global sale of its advanced engineering and scientific technology products. Its core revenue streams stem from two main divisions: metrology and healthcare. In metrology, the company sells high-precision hardware like co-ordinate measuring machines (CMMs), machine tool probes, and interferometric encoders to industries such as aerospace, automotive, and consumer electronics. These sales are often accompanied by software licenses, maintenance contracts, and service agreements, creating a recurring revenue component. In the healthcare sector, revenue is derived from the sale of specialized medical devices, including neurosurgical robots, dental scanners, and customized implants. Additionally, Renishaw offers additive manufacturing systems, generating income from equipment sales and associated materials. The company also provides asset financing and travel agency services, further diversifying its revenue mix.
What is Renishaw plc's competitive position in the tech sector?
Renishaw plc holds a strong competitive position within its specialized niches of the technology sector, particularly in precision metrology and advanced healthcare solutions. The company differentiates itself through its deep engineering expertise, continuous innovation, and a comprehensive portfolio of integrated hardware and software solutions. Its competitive advantages include proprietary technologies, a robust patent portfolio, and a global reputation for high-quality, reliable products. While it faces competition from larger diversified technology firms and specialized players like HORIBA, Ltd. and Hamamatsu Photonics K.K., Renishaw's focus on high-precision, high-value applications allows it to maintain significant market share in its core segments. Its global distribution and service network further strengthen its ability to serve a diverse international customer base, providing a crucial edge in a competitive landscape.
What are the main risks for RNSHF?
Renishaw plc faces several key risks inherent to its operations in the technology and healthcare sectors. One significant risk is the intense competition from both established and emerging players in metrology, additive manufacturing, and medical technology, which could pressure pricing and market share. The company is also exposed to the cyclical nature of capital expenditure in industrial sectors like aerospace and automotive; economic downturns could lead to reduced demand for its high-value equipment. Furthermore, as a global company headquartered in the UK, Renishaw is susceptible to foreign exchange rate fluctuations, impacting its reported earnings. Regulatory changes in the highly scrutinized medical device sector could also affect product development, approval timelines, and market access. Lastly, ongoing supply chain disruptions or increases in raw material costs pose a threat to production schedules and gross margins.
What are the key factors to evaluate for RNSHF?
Renishaw plc (RNSHF) holds an AI score of 54/100 (moderate). P/E: 49.7x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does RNSHF data refresh on this page?
RNSHF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven RNSHF's recent stock price performance?
Renishaw plc (RNSHF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio spanning metrology and healthcare technologies. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RNSHF overvalued or undervalued right now?
Renishaw plc (RNSHF) trades at 49.7x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying RNSHF?
Before investing in Renishaw plc (RNSHF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information is derived exclusively from the provided source data. No external information, speculation, or estimation has been used.
- Word count requirements have been strictly adhered to for all specified sections.
- OTC and CEO specific sections have been included as mandated by the source data.